CompletedNot Applicable

The Effect of Home Based Tele-Exercise on Peritoneal Dialysis Patients

Iran30 participantsStarted 2025-01-29

Plain-language summary

Brief Summary: The objective of the trial is to assess the effect of synchronous home-based tele exercise on daily activity level, functional status and frailty level in Peritoneal Dialysis patients. Condition or disease Intervention/treatment End Stage Renal Disease Peritoneal Dialysis Complication Behavioral: Home-based Tele Exercise

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Aged 18 years and over
✓. At least 3 months of stable peritoneal dialysis (PD) history
✓. Permission from their doctors
✓. Have decision-making capacity to enable them to give informed consent to take part in the study
✓. Have access to a smart device (e.g., smartphone, laptop or tablet), and have internet access

Exclusion criteria

✕. Unstable cardiac status, including angina, decompensated congestive heart failure, or uncontrolled arrhythmias
✕. Active infection or acute medical illness
✕. Hemodynamic instability
✕. Labile glycemic control
✕. Individuals unable to exercise entirely, e.g., lower extremity amputations without feasible alternatives for adapted exercise
✕. Having severe musculoskeletal pain at rest or with minimal activity
✕. Unable to sit, stand or walk unassisted (walking device such as cane or walker allowed)
✕. Having shortness of breath at rest or with activities of daily living (NYHAClass IV)

What they're measuring

Recruitment rate

Timeframe: 1 Month

Retention rate

Timeframe: 3 Months

Adherence rate

Timeframe: 3 Months

Goal Achievement Scale (GAS)

Timeframe: Pre-test and 3 Months Later (Post-test)

Trial details

NCT IDNCT06787599

SponsorPardis Specialized Wellness Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-02

View on ClinicalTrials.gov More End Stage Renal Disease trials